{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:23:04Z","timestamp":1764066184369,"version":"3.45.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371567"],"award-info":[{"award-number":["82371567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the First-Class Discipline Team of Skin & Mucosal Regenerative Medicine of Kunming Medical University","award":["2024XKTDTS10"],"award-info":[{"award-number":["2024XKTDTS10"]}]},{"name":"Xingdian Talent Support Program"},{"name":"Yunnan Provincial Clinical Medical Center for Cutaneous Immunological Diseases","award":["2024YNLCYXZX0033"],"award-info":[{"award-number":["2024YNLCYXZX0033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03935-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:20:16Z","timestamp":1764066016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated expression of SIGLEC8 in skin cutaneous melanoma predicts better prognosis associated with hematopoietic cell lineage pathway"],"prefix":"10.1007","volume":"16","author":[{"given":"Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"3935_CR1","doi-asserted-by":"crossref","unstructured":"Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014;383(9919):816\u2013827.","DOI":"10.1016\/S0140-6736(13)60802-8"},{"issue":"1","key":"3935_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3935_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/bjd.15510","volume":"177","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Green AC, Nijsten T, Weinstock MA, Dellavalle RP, Naghavi M, Fitzmaurice C. The global burden of melanoma: results from the global burden of disease study 2015. Br J Dermatol. 2017;177(1):134\u201340.","journal-title":"Br J Dermatol"},{"issue":"6","key":"3935_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","volume":"136","author":"DC Whiteman","year":"2016","unstructured":"Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 2016;136(6):1161\u201371.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"3935_CR5","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.3390\/ijms23105384","volume":"23","author":"J T\u00edm\u00e1r","year":"2022","unstructured":"T\u00edm\u00e1r J, Lad\u00e1nyi A. Molecular pathology of skin melanoma: Epidemiology, differential Diagnostics, prognosis and therapy prediction. Int J Mol Sci. 2022;23(10):5384.","journal-title":"Int J Mol Sci"},{"key":"3935_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","volume":"63","author":"C Garbe","year":"2016","unstructured":"Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. Eur J Cancer. 2016;63:201\u201317.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3935_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cells10010019","volume":"10","author":"BA Youngblood","year":"2020","unstructured":"Youngblood BA, Leung J, Falahati R, et al. Discovery, Function, and therapeutic targeting of Siglec-8. Cells. 2020;10(1):19.","journal-title":"Cells"},{"key":"3935_CR8","first-page":"136","volume":"1","author":"Y Fang","year":"2025","unstructured":"Fang Y, Kong Y, Rong G, Luo Q, Liao W, Zeng D. Systematic investigation of tumor microenvironment and antitumor immunity with IOBR. Med Res. 2025;1:136\u201340.","journal-title":"Med Res"},{"key":"3935_CR9","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, Yu F, Li L, Huang R, Zhang P, Kadier K, Wang Y, Gu Q, Ding Y, Gu T, Chi H, Zhang S, Wu R, Xu Y, Zhu S, Zheng H, Zhao T, He Q, Qiu X. Optimized dynamic network biomarker Deciphers a High-Resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1:10\u201331.","journal-title":"Med Res"},{"issue":"2","key":"3935_CR10","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye B, Fan J, Xue L, Zhuang Y, Luo P, Jiang A, Xie J, Li Q, Liang X, Tan J, Zhao S, Zhou W, Ren C, Lin H, Zhang P. iMLGAM: integrated machine learning and genetic Algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. iMeta. 2025;4(2):e70011.","journal-title":"iMeta"},{"key":"3935_CR11","doi-asserted-by":"crossref","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science (New York, N.Y.). 2018;359(6371):97\u2013103.","DOI":"10.1126\/science.aan4236"},{"issue":"1","key":"3935_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"12","key":"3935_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"3935_CR14","unstructured":"Liu J, Lichtenberg T, Hoadley KA, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018;173(2):400\u2013e41611."},{"key":"3935_CR15","doi-asserted-by":"publisher","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","DOI":"10.1186\/1471-2105-14-7"},{"issue":"4","key":"3935_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"issue":"5","key":"3935_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"3935_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","volume":"38","author":"S Duan","year":"2020","unstructured":"Duan S, Paulson JC. Siglecs as immune cell checkpoints in disease. Annu Rev Immunol. 2020;38:365\u201395.","journal-title":"Annu Rev Immunol"},{"key":"3935_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cbpa.2021.01.001","volume":"62","author":"G Murugesan","year":"2021","unstructured":"Murugesan G, Weigle B, Crocker PR. Siglec and anti-Siglec therapies. Curr Opin Chem Biol. 2021;62:34\u201342.","journal-title":"Curr Opin Chem Biol"},{"key":"3935_CR20","doi-asserted-by":"crossref","unstructured":"Steyerberg EW. Clinical prediction models: A practical approach to development, validation, and updating. Springer; 2019.","DOI":"10.1007\/978-3-030-16399-0"},{"key":"3935_CR21","doi-asserted-by":"crossref","unstructured":"Harrell FE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Springer; 2015.","DOI":"10.1007\/978-3-319-19425-7"},{"issue":"2","key":"3935_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB, D\u2019Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157\u201372.","journal-title":"Stat Med"},{"key":"3935_CR23","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. Wiley; 2013.","DOI":"10.1002\/9781118548387"},{"key":"3935_CR24","doi-asserted-by":"crossref","unstructured":"Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928\u2013935.","DOI":"10.1161\/CIRCULATIONAHA.106.672402"},{"issue":"6","key":"3935_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AM, Flaherty KT, Balch CM, Thompson JF. Melanoma staging: Evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual. Cancer J Clin. 2017;67(6):472\u201392.","journal-title":"Cancer J Clin"},{"issue":"5","key":"3935_CR26","first-page":"2142","volume":"114","author":"X Liu","year":"2023","unstructured":"Liu X, et al. SIGLEC8 overexpression promotes CcRCC progression via HIF-1\u03b1 signaling. Cancer Sci. 2023;114(5):2142\u201352.","journal-title":"Cancer Sci"},{"issue":"4","key":"3935_CR27","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3390\/ijms22042109","volume":"22","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. First evidence for a role of Siglec-8 in breast cancer. Int J Mol Sci. 2021;22(4):2109.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3935_CR28","first-page":"10367","volume":"7","author":"Q Wang","year":"2016","unstructured":"Wang Q, et al. Decreased Siglec-8 predicts poor prognosis in gastric cancer. Oncotarget. 2016;7(9):10367\u201376.","journal-title":"Oncotarget"},{"key":"3935_CR29","doi-asserted-by":"crossref","first-page":"586820","DOI":"10.3389\/fonc.2020.586820","volume":"10","author":"F Xu","year":"2020","unstructured":"Xu F, et al. SIGLEC family genes in tumor immunity. Front Oncol. 2020;10:586820.","journal-title":"Front Oncol"},{"issue":"10","key":"3935_CR30","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1158\/1078-0432.CCR-08-0037","volume":"14","author":"T Bonome","year":"2008","unstructured":"Bonome T, et al. Gene expression signature of aggressive serous ovarian cancer. Clin Cancer Res. 2008;14(10):3185\u201394.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3935_CR31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/all.14724","volume":"76","author":"P Engeroff","year":"2021","unstructured":"Engeroff P, Vogel M. The role of CD23 in the regulation of allergic responses. Allergy. 2021;76(7):1981\u20139.","journal-title":"Allergy"},{"issue":"1","key":"3935_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jaci.2019.07.045","volume":"145","author":"P Engeroff","year":"2020","unstructured":"Engeroff P, Caviezel F, Mueller D, Thoms F, Bachmann MF, Vogel M. CD23 provides a noninflammatory pathway for IgE-allergen complexes. J Allergy Clin Immunol. 2020;145(1):301\u2013e3114.","journal-title":"J Allergy Clin Immunol"},{"key":"3935_CR33","doi-asserted-by":"publisher","first-page":"620427","DOI":"10.3389\/fimmu.2021.620427","volume":"12","author":"KG Kov\u00e1cs","year":"2021","unstructured":"Kov\u00e1cs KG, M\u00e1csik-Valent B, Matk\u00f3 J, Bajtay Z, Erdei A. Revisiting the coreceptor function of complement receptor type 2 (CR2, CD21); coengagement with the B-Cell receptor inhibits the Activation, Proliferation, and antibody production of human B cells. Front Immunol. 2021;12:620427.","journal-title":"Front Immunol"},{"issue":"6","key":"3935_CR34","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3324\/haematol.2019.243543","volume":"105","author":"G Pavlasova","year":"2020","unstructured":"Pavlasova G, Mraz M. The regulation and function of CD20: an enigma of B-cell biology and targeted therapy. Haematologica. 2020;105(6):1494\u2013506.","journal-title":"Haematologica"},{"issue":"11","key":"3935_CR35","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"CH Koh","year":"2023","unstructured":"Koh CH, Lee S, Kwak M, Kim BS, Chung Y. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med. 2023;55(11):2287\u201399.","journal-title":"Exp Mol Med"},{"issue":"6","key":"3935_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/glycob\/cww024","volume":"26","author":"BS Bochner","year":"2016","unstructured":"Bochner BS. Siglecting the allergic response for therapeutic targeting. Glycobiology. 2016;26(6):546\u201352.","journal-title":"Glycobiology"},{"issue":"7858","key":"3935_CR37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, Sugiura A, Cohen AS, Ali A, Do BT, Muir A, Lewis CA, Hongo RA, Young KL, Brown RE, Todd VM, Huffstater T, Abraham A, O\u2019Neil RT, Wilson MH, Rathmell WK. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021;593(7858):282\u20138.","journal-title":"Nature"},{"key":"3935_CR38","unstructured":"He C. Research progress in the role of eosinophils in tumor immunotherapy. Chin J Cancer Biotherapy. 2023;30.2."},{"key":"3935_CR39","doi-asserted-by":"crossref","unstructured":"Shan-Shan Y, Feng-Hou G. Molecular mechanism of tumor cell immune escape mediated by CD24\/Siglec-10, Front Immunol. 2020;11.","DOI":"10.3389\/fimmu.2020.01324"},{"key":"3935_CR40","unstructured":"Wei YQ, Lyu LH, Li M. Research progress on eosinophils in lung cancer. Chin J Prev Med. 2023;5711:1895\u2013900."},{"key":"3935_CR41","unstructured":"Limei S, Alison M, Karthik S, Whitney T, W., Samuel K, L. Siglec15\/TGF-\u03b2 bispecific antibody mediates synergistic Anti-tumor response against 4T1 triple negative breast cancer in mice. Bioeng Transl Med. 2024."},{"issue":"6","key":"3935_CR42","first-page":"451","volume":"21","author":"JA O\u2019Sullivan","year":"2022","unstructured":"O\u2019Sullivan JA, Carroll DJ, Bochner BS, von Gunten S. Siglecs as immunomodulatory targets in human disease. Nat Rev Drug Discovery. 2022;21(6):451\u201369.","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"3935_CR43","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/cancers13051146","volume":"13","author":"S Julien","year":"2021","unstructured":"Julien S, Videira PA, Delannoy P. Sialyl-Tn antigen: A cancer-associated carbohydrate antigen with a short but sweet history. Cancers. 2021;13(5):1146.","journal-title":"Cancers"},{"issue":"10","key":"3935_CR44","first-page":"597","volume":"22","author":"MM Fuster","year":"2022","unstructured":"Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2022;22(10):597\u2013616.","journal-title":"Nat Rev Cancer"},{"key":"3935_CR45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fonc.2020.00394","volume":"10","author":"E Rodrigues","year":"2020","unstructured":"Rodrigues E, Macauley MS, Reis CA. Targeting cancer glycosylation for cancer immunotherapy: exploiting the glyco-code. Front Oncol. 2020;10:394.","journal-title":"Front Oncol"},{"key":"3935_CR46","first-page":"289","volume":"40","author":"S Pillai","year":"2022","unstructured":"Pillai S, Netravali IA, Cariappa A, Mattoo H. Siglecs and immune regulation. Annu Rev Immunol. 2022;40:289\u2013322.","journal-title":"Annu Rev Immunol"},{"key":"3935_CR47","first-page":"1154765","volume":"14","author":"S Ghosh","year":"2023","unstructured":"Ghosh S, Hosseini R, Liao H, Quirke P. Immune cell glycosylation in the tumor microenvironment: implications for immunotherapy. Front Immunol. 2023;14:1154765.","journal-title":"Front Immunol"},{"issue":"10","key":"3935_CR48","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","volume":"29","author":"GV Long","year":"2011","unstructured":"Long GV, Menzies AM, Nagrial AM, et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol. 2011;29(10):1239\u201346.","journal-title":"J Clin Oncol"},{"issue":"6230","key":"3935_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi NA, Hellmann MD, Snyder A, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 Blockade in non-small cell lung cancer. Science. 2015;348(6230):124\u20138.","journal-title":"Science"},{"issue":"7","key":"3935_CR50","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681\u201396.","journal-title":"Cell"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03935-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03935-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03935-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:20:24Z","timestamp":1764066024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03935-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3935"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03935-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study utilized publicly available, de-identified data from The Cancer Genome Atlas (TCGA). Since no new human participants were recruited and no identifiable private information was accessed or generated, ethical approval for this specific retrospective analysis was not required. The original TCGA study protocols received approval from the relevant Institutional Review Boards (IRBs). Written informed consent was obtained from all participants in the original TCGA study. Given the exclusive use of de-identified, publicly available data from TCGA in this secondary analysis, obtaining new consent to participate was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from all participants during their enrollment in the original TCGA study. Given the exclusive use of de-identified, aggregated data in this analysis, separate consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2159"}}